Fingolimod to be reviewed by EU and US after 11 deaths
Breaking news:
European and U.S. regulators are reviewing
Novartis AG’s
Gilenya pill for multiple sclerosis after reports of 11 deaths among patients who took the drug. The shares fell the most in more than five months......
For full report see
Bloomberg